Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure - Wikidata - wikimedia - TriplyDB

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure

http://www.wikidata.org/entity/Q28080114

about

SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial.Recent advances in understanding/managing type 2 diabetes mellitus.Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes.Dietary Cadmium Intake and Its Effects on Kidneys.

P2860

Q47095186-0F3B37C4-CEEA-4ACA-8698-564E852E70EA Q47161786-BE29673B-30A6-49DA-8F7C-8CCBC0EE9661 Q48141985-4FC8994C-93A7-460E-A32F-FB44C101093B Q55260734-C17A8B0E-7A06-43E0-BA62-4C1622D1823C

P2860

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure

http://www.wikidata.org/entity/Q28080114

description

2016 nî lūn-bûn

@nan

2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure

@ast

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure

@en

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure

@nl

type

label

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure

@ast

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure

@en

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure

@nl

prefLabel

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure

@ast

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure

@en

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure

@nl

P1433

Q28080114-72D68C2A-83E6-459C-A58F-430A4898130D

P1476

Q28080114-0D73D6AF-41F4-435D-8E90-B880AF8CC71F

P2093

Q28080114-127BBAAA-B641-421B-9C83-58AC8EC88C3C

P275

Q28080114-ACD0CDD6-6A30-474A-A428-C6325C62ACDA

P2860

Q28080114-016969F8-EDA1-47F7-90A6-E08ECB8A5C34

Q28080114-066B6F78-6567-49EF-83E1-6AD4B969C829

Q28080114-0AB5E014-A6E8-4E69-A81E-47A3F0A81742

Q28080114-0E9D0336-59B3-4249-9A14-207AD8AC5480

Q28080114-0FFF55AE-1BD4-4E4D-A724-756F9AB29DAD

Q28080114-14AB7457-5F68-4833-9C1E-2C3182DCB018

Q28080114-2450A498-1212-4FEE-9DFE-D2C6A20614D1

Q28080114-25F43972-E1C7-4B59-A666-A5CB88D222E9

Q28080114-266086F4-C3B9-4E4C-A8F3-BC5FAFEA057E

Q28080114-29B7A50F-D958-4D20-9954-67D8E6D6ECE4

P304

Q28080114-11204E76-1F4F-4253-BEDF-1DD49C085433

P31

Q28080114-1D832B5B-99A8-41CE-9D06-5B319681932E

Q28080114-84EA7271-5A2F-41EA-BA81-FBB643E827D4

P3181

Q28080114-03B36B6B-A1C1-4F25-A960-A69CEC336551

P356

Q28080114-2435B165-1774-498D-86CD-37DA0EEA6F65

P407

Q28080114-922AD863-C241-40B2-AC5B-6F6E9F76A130

P478

Q28080114-1FE7EC34-CA09-40CF-A17F-A0B5F9CB9709

P5008

Q28080114-C1630695-D639-4026-B715-DE7DC642133A

P577

Q28080114-41195F27-B10C-4A47-9C31-510C97D6BD19

P698

Q28080114-01771801-DF58-423C-9078-8CE0F4981408

P921

Q28080114-3A9A937A-135E-42E0-82DD-758F46CDFEBE

Q28080114-68968475-762E-48EB-84E8-7C8961531A97

Q28080114-C7C6948B-7A57-45E5-B6D7-44622CA8BB43

Q28080114-CBB40EA9-CEDB-400D-A9CF-CCB0D5472CCC

Q28080114-E5C67221-739A-47A1-9986-576C0850F315

P932

Q28080114-9EB86F18-675B-4206-A041-FCD589627F5F

P3181

P356

P1433

Vascular Health and Risk Management

P1476

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure

@en

P2093

James Reed

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

An Effective Approach to High Blood Pressure Control: A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention

Long-term effects of weight-reducing drugs in hypertensive patients

Blood pressure targets for hypertension in people with diabetes mellitus

Long-term effects of weight-reducing diets in hypertensive patients

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Novel hypothesis to explain why SGLT2 inhibitors inhibit only 30-50% of filtered glucose load in humans

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people

P304

393-405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2769119

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/VHRM.S111991

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27822054

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

mechanism of action

arterial hypertension

genitourinary system

maturity-onset diabetes of the young

P932

5089867

http://www.w3.org/2001/XMLSchema#string